The College engages in a range of public consultation activities prior to implementing or making changes to important aspects of registered nursing regulation, including, but not limited to:
- Practice Expectations,
- Regulations, and
- Practice Directions
The College seeks the input of registrants, the public, and other stakeholders including government, Manitoba’s other regulated health professions, employers, nursing educators, and other affected parties as applicable to the changes or new measures under consideration. A diverse range of input helps strengthen the College's overall ability to protect and serve the public interest through quality registered nursing regulation.
Consultation on Amendments to the College's General Regulation
As per subsection 82(6) of The Regulated Health Professions Act, the Council of the College of Registered Nurses of Manitoba is seeking feedback regarding a proposed amendment to the College of Registered Nurses of Manitoba General Regulation. These amendments are administrative in nature and will continue existing authorities.
Currently, all drugs and medical devices covered by Pharmacare are prescribed by regulation under The Prescription Drugs Cost Assistance Act. Changes to this Act will enable the Minister to specify by policy the drugs and devices covered by Pharmacare, rather than prescribing this list by regulation. When these changes to the Act are proclaimed into force, the list of drugs and devices currently included in the Specified Drugs Regulation under the Act will be repealed.
Section 2.24 of the College of Registered Nurses of Manitoba General Regulation currently contains a reference to the Specified Drugs Regulation that will need to be updated so that Registered Nurse (Nurse Practitioner)s can continue prescribing devices covered by Pharmacare. The proposed amendment is as follows:
2.24 A registered nurse (nurse practitioner) may prescribe any device listed in the Specified Drugs Regulation, Manitoba Regulation 6/95.
2.24 A registered nurse (nurse practitioner) may prescribe any device for which a benefit may be paid under clause 8.2(1)(a) of The Prescription Drugs Cost Assistance Act.
A copy of the amending regulation can be found here.
Please send comments/feedback to email@example.com by end of day on Monday, September 20th 2021.